ARCHIVES

FDA approves Irinotecan, Days After ODAC Meeting

This article is from The Cancer Letter archive.

Vol. 22 No. 25 | June 21, 1996

Download PDF Visit The Full Archive

Related Articles

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011